New publication on Duloxetine exposure
The aim of the study is to evaluate the association between duloxetine exposure [...]
Read the publication on diabetes treatment and the SWEET-project
Read this publication published in Diabetes Technology & Therapeutics. This publication aims to [...]
ApHER in a cooperation with EasyTrial ApS and IWA Consulting ApS
ApHER has entered a new cooperation with EasyTrial ApS and IWA Consulting ApS. [...]
MedEngine acquires ApHER to offer Nordic real-world data solutions to global pharmaceutical companies
Helsinki, Finland – March 4th, 2021. MedEngine Oy announced today that it has [...]
ApHER presented a poster at ESMO 2020
ApHER presented a poster “Treatment patterns and survival for small cell lung cancer [...]
New ApHER publication
Take a look at our most recent publication published in the journal BMC [...]
Welcome to ApHER News
Who we are ApHER is an independent academic research organization and partner [...]
Take a look at our most recent publication
Have a look at our most recent publication published in the Pharmacoepidemiology & [...]
Prof. Anders Green – Appointed Member of the International Scientific Board of the Dasman Diabetes Institute
As of April 1st 2020, Professor Anders Green has been appointed Member of [...]
ApHER at EMUC19
ApHER has presented results from the CEDAR Study in the poster “The past, [...]
ApHER at WOOL2LOOP project meeting in Belgium
Last week ApHER participated at the 2nd Project Meeting of the Horizon2020 WOOL2LOOP [...]
Thanks for the large attendance during our breakout session at ISPOR
Thanks for the large attendance during our breakout session at ISPOR in Copenhagen [...]
Hope to see you at ISPOR in Copenhagen!
Besides leading a workshop on the Nov 6th 09:45-10:45 on Nordic studies based [...]
ApHER at the H2020 for the Circular Economy & Transforming Industry Brokerage Event
Meet ApHER at the H2020 for the Circular Economy & Transforming Industry Brokerage [...]
Professor Anders Green at the EASD 2019
On September 18 professor Anders Green from ApHER gave an oral presentation at [...]
We are delighted to welcome our new team member
The transition to circular economy is keeping us busy in ApHER. We are [...]
“The hospitals will see far more patients with non-small cell lung cancer in the future.”
The Danish media "Onkologisk Tidsskrift" has written an article about the findings of [...]
Professor Anders Green from ApHER has been invited to give an oral presentation at the 55th EASD Annual Meeting in Barcelona 2019
Professor Anders Green from ApHER has been invited to give an oral presentation [...]
ApHER at the IASLC 2019 World Conference on Lung Cancer in Barcelona
ApHER was present at the IASLC 2019 World Conference on Lung Cancer in [...]
ApHER at the DHL Relay 2019
Yesterday, ApHER Race Team defied the heat and completed this year’s DHL Relay [...]
ApHER is hosting NewSOL GA5 project meeting in Copenhagen
ApHER is hosting NewSOL GA5 project meeting in Copenhagen (July 8-10). Read more [...]
Seminar: “Future of Energy Storage”
ApHER will participate in the seminar “Future of Energy Storage”, which will take [...]
Take a look at our most recent publications within 3 areas
Take a look at our most recent publications within 3 areas. Our paper [...]
ApHER conducted analyses in a project recently presented at ISPOR 2019, New Orleans
Anastasija Komkova and Thomas Fast from ApHER conducted analyses in a research project [...]
ApHER attending kick-off meeting of EU Horizon 2020 project WOOL2LOOP
The 13th of June Birgitte Holt Andersen and Anastasija Komkova from ApHER attended [...]
Nordic Evidence Leaders Forum – Stockholm May 14-15 2019
Thomas was a speaker at the Nextlevel Life Sciences Conference in Stockholm in [...]
ApHER in European Research Project on Circular Economy
Circular economy innovation project utilizing mineral wool waste from building and demolition received [...]
WHO at ApHER
On Monday March 18th 2019, ApHER hosted a meeting in a working group [...]
Is your organization ready for the new data demands in the wake of the medical device regulation?
Is your organization ready for the new data demands in the wake of [...]
Managing Director Martha Emneus gave an invited presentation at the marketing compliance network meeting of Atrium
On March 13 Managing Director Martha Emneus from ApHER gave an invited presentation [...]
Thomas Fast at the 8th National Health Economic Conference
This Wednesday Thomas Fast attended the 8th National Health Economic Conference in Örebro [...]
New publication: Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study
Our paper "Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality [...]
Meet Thomas Fast from ApHER at the Nordic Evidence Leaders Forum in Stockholm
Demonstrating the safety profile of a new drug intervention is a pre-requisite for [...]
Thomas Fast presented our Narcolepsy project at the 6th Nordic Narcolepsy Symposium in Uppsala
Presenting work and receiving feedback is a rewarding part in our scientific work. [...]
Prof. Anders Green at the 5th International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications
Is diabetes per se a risk factor for developing cancer? Or is diabetes [...]
MedTech Access – Leaders Forum in Berlin 3-5 December
A CE-mark is not enough to bring medical device products to the market. [...]
New publication: Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.
By pooling Nordic health data on medical devices & pharmaceuticals, and analyzing it [...]
ApHER at ISPOR Barcelona 2018: Cost of multiple sclerosis
ApHER participated at ISPOR Europe 2018 and presented a study “COSTS OF MULTIPLE [...]
Danish Cancer Research Days 30-31 August 2018
ApHER participated at the cancer research days presenting the CEDAR study, a nationwide, [...]
ApHER Race team at the DHL Relay
Monday the 28th of August ApHER participated in the DHL Relay in Copenhagen. [...]
Earth Overshoot Day – August 1st 2018
It’s our party. But it ends today. By Aug 1st the global natural resources [...]
New study: Many patients go for years without seeing a sclerosis doctor
Six out of ten of the sclerosis patients who are not in disease-modifying [...]
It is a good investment to prevent the development of lifestyle diseases such as diabetes
A poorly regulated diabetes patient is costly for both the public healthcare system [...]
Register studies of diabetes treatment arouse method discussions
Randomized studies of SLGT-2 inhibitors and GLP-1 receptor agonists are now followed-up by [...]
Danish register studies are in world class – but threatened
Denmark is a world champion in register studies which has also provided invaluable [...]
Annual meeting of the Scandinavian Society for the study of diabetes
Professor Anders Green gave an invited presentation on the epidemiological results from the [...]
Benchmarking II
ApEHR has produced a report on behalf on the Danish Multidisciplinary Cancer Groups [...]
Real life treatment patterns and outcomes in advanced Melanoma patients in Italy and Sweden: The development of a Multi Country Database
This pilot study aims to create an international data platform for real world [...]
UTURN – a life without pills
The program UTURN - a life without pills on DR1 (Danish national television), [...]
Staying in good health adds economic value to our societies
In collaboration, Dr. Hans Martens and APEHR have completed a blog discussing the [...]
ApEHR in the Danish media: New study trend boosts growing business
Studies on how medicine works in the real world are being used to [...]
Status of the diabetes situation in Denmark: Social inequality in diabetes morbidity
PhD and M.Sc. Camilla Sortsø gives a status on the diabetes morbidity in [...]
Decomposing inequality in diabetes patients’ morbidity patterns, survival and health care usage in Denmark
In collaboration, APEHR and the Centre of Health Economics Research (COHERE) have completed [...]
Different patterns of Finasteride use in males with prostate hyperplasia across Nordic countries
The Nordic countries Denmark, Finland, Norway and Sweden have many cross-national similarities regarding [...]
Horizon2020 Info Day on Smart Cities & Communities
ApEHR participated in Horizon2020 Info Day on Smart Cities & Communities. ApEHR can [...]
The Diabetes Impact Study in the Danish media: Every 10th Dane will have Diabetes in 10 Years
The newest publication of the Diabetes Impact Study reveals the dramatic forecasts of [...]
Prensentation of Diabetes Impact Study Results on August 20th 2015
On August 20th 2015, APEHR presented the results of the Diabetes Impact Study [...]
The Diabetes Impact Study: Incidence, morbidity, mortality, and prevalence of diabetes in Denmark
In cooperation wih the University of Southern Denmark, APEHR has just published an [...]
Real World Evidence: Clinical evidence – from the real world
With the Danish parliament in front, Denmark is preparing on becoming the internationally [...]
Prof. Anders Green and the ApEHR team teach and speak at several seminars on cancer, epidemiology, health economics and diabetes
Prof. Anders Green and the APEHR team have been invited to teach and [...]
Validation of the Danish National Diabetes Register
The Danish National Diabetes Register (NDR) was established in 2006 and builds on [...]
TænkeTanken at the People’s Meeting “Folkemødet 2014” on Bornholm
Prof. Anders Green shares his views on the future's diabetes strategy on the [...]
Prof. Anders Green speaks at the 2014 Cancer Conference in Copenhagen
On the 6th of March 2014 The Danish Cancer Society and The Danish [...]
The cancer tsunami in Denmark
The December issue of Perspektiv og Debat puts spotlight on cancer treatment and [...]
The prospects of Real Word Data
Prof. Anders Green speaks about a generation of Real Word Data in lung [...]
Diabetes Impact Study 2013
The Danish Diabetes Association (DDA) has initiated an analysis of diabetes related costs in [...]